Allergy

The role of small airways in monitoring the response to asthma treatment: what is beyond FEV₁?
pp. 1563-1569(7)
Authors: Scichilone, N.; Battaglia, S.; Olivieri, D.; Bellia, V.

The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA²LEN meta-analysis
pp. 1570-1579(10)
Authors: Compalati, E.; Passalacqua, G.; Bonini, M.; Canonica, G. W.

Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis
pp. 1580-1587(8)
Authors: Niebuhr, M.; Lutat, C.; Sigel, S.; Werfel, T.

Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis
pp. 1588-1596(9)
Authors: Brandt, C.; Pavlovic, V.; Radbruch, A.; Worm, M.; Baumgrass, R.

Neutrophilic airway inflammation is a main feature of induced sputum in nonatopic asthmatic children
pp. 1597-1601(5)
Authors: Drews, A. C.; Pizzichini, M. M. M.; Pizzichini, E.; Pereira, M. U.; Pitrez, P. M.; Jones, M. H.; Sly, P. D.; Stein, R. T.

Counter regulation of the high affinity IgE receptor, FcεRI, on human airway dendritic cells by IL-4 and IL-10
pp. 1602-1607(6)
Authors: Faith, A.; Singh, N.; Chevretton, E.; Roberts, D.; Lee, T.; Corrigan, C.; Hawrylowicz, C.

Association of the toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis
pp. 1608-1615(8)
Authors: Oh, D.-Y.; Schumann, R. R.; Hamann, L.; Neumann, K.; Worm, M.; Heine, G.

Plasma levels and skin-eosinophil-expression of vascular endothelial growth factor in patients with chronic urticaria
pp. 1616-1622(7)
Authors: Tedeschi, A.; Asero, R.; Marzano, A. V.; Lorini, M.; Fanoni, D.; Berti, E.; Cugno, M.

Association and interaction analyses of eight genes under asthma linkage peaks
pp. 1623-1628(6)
Authors: Ferreira, M. A. R.; Zhao, Z. Z.; Thomsen, S. F.; James, M.; Evans, D. M.; Postmus, P. E.; Kyvik, K. O.; Backer, V.; Boomsma, D. I.; Martin, N. G.; Montgomery, G. W.; Duffy, D. L.

Effect of natural seasonal pollen exposure and repeated nasal allergen provocations on elevation of exhaled nitric oxide
pp. 1629-1634(6)
Authors: Bergmann-Hug, K.; Wirth, R.; Henseler, M.; Helbling, A.; Pichler, W. J.; Schnyder, B.

IgE cross-reactivity between Ascaris and domestic mite allergens: the role of tropomyosin and the nematode polyprotein ABA-1
pp. 1635-1643(9)
Authors: Acevedo, N.; Sánchez, J.; Erler, A.; Mercado, D.; Briza, P.; Kennedy, M.; Fernandez, A.; Gutierrez, M.; Chua, K. Y.; Cheong, N.; Jiménez, S.; Puerta, L.; Caraballo, L.

Cross-reactivity and tolerability of imipenem in patients with delayed-type, cell-mediated hypersensitivity to β-lactams
pp. 1644-1648(5)
Authors: Schiavino, D.; Nucera, E.; Lombardo, C.; Decinti, M.; Pascolini, L.; Altomonte, G.; Buonomo, A.; Patriarca, G.

Fitness, daily activity and body composition in children with newly diagnosed, untreated asthma
pp. 1649-1655(7)
Authors: Vahlkvist, S.; Pedersen, S.

GA²LEN skin test study III: Minimum battery of test inhalent allergens needed in epidemiological studies in patients
pp. 1656-1662(7)
Authors: Bousquet, P.-J.; Burbach, G.; Heinzerling, L. M.; Edenharter, G.; Bachert, C.; Bindslev-Jensen, C.; Bonini, S.; Bousquet-Rouanet, L.; Demoly, P.; Bresciani, M.; Bruno, A.; Gjomarkaj, M.; Canonica, G. W.; Darsow, U.; Durham, S.; Fokkens, W. J.; Giavi, S.; Gramiccioni, C.; Papadopoulos, N. G.; Haahtela, T.; Kowalski, M. L.; Magyar, P.; Muraközi, G.; Orosz, M.; Röhnelt, C.; Stingl, G.; Todo-Bom, A.; von Mutius, E.; Wiesner, A.; Wöhrl, S.; Bousquet, J.; Zuberbier, T.

Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis
pp. 1663-1670(8)
Authors: Holmberg, K.; Tonnel, A.-B.; Dreyfus, I.; Olsson, P.; Cougnard, J.; Mesbah, K.; Devillier, P.

Effect of improved home ventilation on asthma control and house dust mite allergen levels
pp. 1671-1680(10)
Authors: Wright, G. R.; Howieson, S.; McSharry, C.; McMahon, A. D.; Chaudhuri, R.; Thompson, J.; Donnelly, I.; Brooks, R. G.; Lawson, A.; Jolly, L.; McAlpine, L.; King, E. M.; Chapman, M. D.; Wood, S.; Thomson, N. C.

Natural killer T cells expressing IFN-γ and IL-4 in lesional skin of atopic eczema
pp. 1681-1684(4)
Authors: Simon, D.; Kozlowski, E.; Simon, H.-U.

Letter to the editor
pp. 1685-1685(1)
Author: Kontou-Fili, K.

Occupational asthma IgE mediated due to Chrysonilia sitophila in coffee industry
pp. 1686-1687(2)
Authors: Monzón, S.; Gil, J.; Ledesma, A.; Ferrer, L.; San Juan, S.; Abós, T.

Immunoglobulin E reactivity to Arizona cypress pollen extracts: evidence for a 35-kDa allergen
pp. 1687-1688(2)
Authors: Shahali, Y.; Pourpak, Z.; Moin, M.; Mari, A.; Majd, A.

Hypersensitivity systemic reaction to cactus fruit (Opuntia ficus-indica)
pp. 1689-1690(2)
Authors: García-Menaya, J. M.; Cordobés-Durán, C.; Bobadilla, P.; Ledesma, A.; Pérez-Rangel, I.

Human milk fortifier in preterm babies: source of cow's milk protein sensitization?
pp. 1690-1691(2)
Authors: Vlieghe, V.; Roches, A. D.; Payot, A.; Lachance, C.; Nuyt, A. M.

Codeine-induced generalized dermatitis and tolerance to other opioids
pp. 1692-1692(1)
Authors: Orjales, R. N.; Carballada, F.; Carballas, C.; Boquete, M.

Eosinophilic panniculitis: a new form of local reaction with specific immunotherapy
pp. 1692-1693(2)
Authors: Koca Kalkan, I.; Baccioglu, A.; Kalpaklioglu, F.

IgE-mediated allergy to pristinamycin: the value of skin tests and basophil activation tests
pp. 1694-1694(1)
Authors: Bensaid, B.; Rozieres, A.; Berard, F.; Bienvenu, J.; Nicolas, J. F.

Allergy from giant pumpkin (Cucurbita maxima) is not a fairy tale
pp. 1694-1696(3)
Authors: Hagendorens, M. M.; Carrette, M.; Bridts, C. H.; Stevens, W. J.; Ebo, D. G.

Corrigendum
pp. 1697-1697(1)